Arctic Bioscience AS (OSL:ABS) Moat Score: 0/10 (As of Jul. 11, 2026)


OSL:ABS Arctic Bioscience AS OSL:ABS
55 GF Score
Price kr3.19
GF Value kr10.62
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Arctic Bioscience AS Moat Score?

Arctic Bioscience AS has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Arctic Bioscience AS has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Arctic Bioscience AS might have No Moat - No discernible moat.

Arctic Bioscience AS  (OSL:ABS) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Arctic Bioscience AS Moat Score Related Terms

OSL:ABS
55GF Score
Arctic Bioscience AS OSL:ABS
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Arctic Bioscience AS (OSL:ABS) Overvalued in 2026?

Based on GuruFocus' analysis, Arctic Bioscience AS stock appears to be undervalued. The current stock price of kr3.19 is trading 70% below its estimated GF Value™ of kr10.62. GuruFocus considers Arctic Bioscience AS to be Possible Value Trap.

Key valuation signals for OSL:ABS:

  • Moat Score: 0
  • GF Value™: kr10.62 vs. price of kr3.19 (70% below fair value)
  • GF Score™: 55/100 with 6 warning signs

No single metric tells the full story. See the OSL:ABS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arctic Bioscience AS Business Description

Other Exchanges 9TD:Germany
Address Industrivegen 42, Orsta, NOR, 6155
Arctic Bioscience AS is a clinical-stage biotechnology company working to develop drug candidates within the areas of autoimmune and inflammatory diseases. It is developing pharmaceutical and commercializing nutraceutical products based on bioactive marine compounds, including lipids essential to maintaining cell membranes. The company's proprietary extraction technology is used to extract membrane fats from marine raw materials, such as herring roe and algae. Geographically, the company operates in Norway, the Americas, Europe, and APAC, with the majority of the revenue derived from the Americas.
55GF Score

Get the complete analysis for OSL:ABS

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.19
Price
kr10.62
GF Value